These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Should nonalcoholic fatty liver disease be renamed? Loria P; Lonardo A; Carulli N Dig Dis; 2005; 23(1):72-82. PubMed ID: 15920328 [TBL] [Abstract][Full Text] [Related]
11. The central role of the non alcoholic fatty liver disease in metabolic syndrome. Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Graur M Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):425-31. PubMed ID: 23077931 [TBL] [Abstract][Full Text] [Related]
12. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A; J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218 [TBL] [Abstract][Full Text] [Related]
13. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. Brzozowska MM; Ostapowicz G; Weltman MD J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335 [TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients. Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Milic S; Orlic L Med Hypotheses; 2014 Feb; 82(2):205-8. PubMed ID: 24365277 [TBL] [Abstract][Full Text] [Related]
15. The clinical aspects of non-alcoholic fatty liver disease. Björnsson E Minerva Gastroenterol Dietol; 2008 Mar; 54(1):7-18. PubMed ID: 18299664 [TBL] [Abstract][Full Text] [Related]